You have 9 free searches left this month | for more free features.

EBNA1

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • Stanford, California
    Stanford University
Mar 31, 2022

Nasopharyngeal Carcinoma Trial in Zhongshan, Wuzhou (Blood and saliva, P85-Ab, EBNA1-IgA, VCA-IgA and EBV DNA, Fiberoptic

Recruiting
  • Nasopharyngeal Carcinoma
  • Blood and saliva
  • +2 more
  • Zhongshan, Guangdong, China
  • +1 more
Jul 20, 2022

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Nasopharyngeal Carcinoma Trial in Zhongshan (participants will undergo dual-energy CT and endoscopy)

Recruiting
  • Nasopharyngeal Carcinoma
  • participants will undergo dual-energy CT and endoscopy
  • Zhongshan, Guangdong, China
    Zhongshan People's Hospital
May 22, 2023

Multiple Sclerosis Trial in London (Famciclovir)

Recruiting
  • Multiple Sclerosis
  • London, United Kingdom
    Royal London Hospital, Barts Health NHS Trust
Mar 7, 2022

Occurrence of Antibodies Cross-reacting With Autoantigens in

Recruiting
  • Epstein-Barr Virus (EBV) Infection
  • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Nov 8, 2021

Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV antibodies test
  • EBV DNA test
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022

Nasopharyngeal Cancer, Epstein Barr Virus Infections Trial in United Kingdom (MVA-EBNA1/LMP2 vaccine)

Completed
  • Nasopharyngeal Cancer
  • Epstein Barr Virus Infections
  • MVA-EBNA1/LMP2 vaccine
  • Edgbaston, Birmingham, United Kingdom
  • +4 more
Jul 16, 2018

Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Tongue image
  • Zhuhai, China
    The Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023

Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • PK Blood Collection
  • +2 more
  • (no location specified)
Nov 1, 2022

Neurodegeneration in Multiple Sclerosis -Preclinical Study

Not yet recruiting
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • +2 more
  • Peripheral blood withdrawal
  • Pozzilli, Isernia, Italy
  • +2 more
Feb 15, 2022

NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)

Completed
  • NonHodgkin Lymphoma
  • +6 more
  • EBVST Cells
  • Nivolumab
  • Houston, Texas
  • +1 more
Jul 19, 2021

Nasopharyngeal Cancer, Epstein-Barr Virus Infections Trial in Hong Kong (Recombinant Epstein-Barr Virus (EBV) Vaccine)

Completed
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Infections
  • Recombinant Epstein-Barr Virus (EBV) Vaccine
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021

Physiological and Cognitive Changes in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • Buffalo, New York
    Jacobs Institute
Mar 9, 2022

Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma Trial in

Active, not recruiting
  • Ann Arbor Stage IIB Hodgkin Lymphoma
  • +5 more
  • Bleomycin Sulfate
  • +11 more
  • Birmingham, Alabama
  • +198 more
Sep 16, 2022

Identify Individuals Susceptible to Nasopharyngeal Carcinoma

Terminated
  • Nasopharyngeal Neoplasms
    • Taiwan, China
      National Taiwan University
    Jun 3, 2020

    Nasopharyngeal Carcinoma, EBV Related Carcinoma Trial in Brescia, Milan (Denosumab Inj 120 MG/1.7ML, Chemotherapy as clinical

    Recruiting
    • Nasopharyngeal Carcinoma
    • EBV Related Carcinoma
    • Denosumab Inj 120 MG/1.7ML
    • Chemotherapy as clinical standard of care
    • Brescia, Italy
    • +1 more
    Feb 13, 2020

    Nasopharyngeal Carcinoma Trial in Fuzhou (EBV-TCR-T (YT-E001) cells)

    Unknown status
    • Nasopharyngeal Carcinoma
    • EBV-TCR-T (YT-E001) cells
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Aug 9, 2020

    Transfusion-related EBV Infection Among Allogeneic Stem Cell

    Unknown status
    • Lymphoproliferative Disorders
    • Determining the source of EBV in severe EBV infections
    • Vancouver, British Columbia, Canada
    • +2 more
    Jul 20, 2015

    Lung Cancer Trial in Milan (EBNA with ROSE, standard EBNA)

    Completed
    • Lung Cancer
    • EBNA with ROSE
    • standard EBNA
    • Milan, Italy
      Clinica di Malattie dell'Apparato Respiratorio, Ospedale San Pao
    May 19, 2014

    Nasopharyngeal Tumors, Epstein-Barr Virus Infections Trial in Hong Kong (MVA Vaccine)

    Completed
    • Nasopharyngeal Neoplasms
    • Epstein-Barr Virus Infections
    • MVA Vaccine
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Prince of Wales Hospital
    Dec 21, 2011

    Nasopharyngeal Carcinoma Trial in Changsha (DNAzyme targeting EBV-LMP1 (DZ1), Saline)

    Completed
    • Nasopharyngeal Carcinoma
    • DNAzyme targeting EBV-LMP1 (DZ1)
    • Saline
    • Changsha, Hunan, China
      XiangYa Hospital, Central South University
    Oct 6, 2011

    Screening for Nasopharyngeal Carcinoma in High Risk Populations

    Unknown status
    • Nasopharyngeal Cancer
    • Screening
      • Sihui, Guangdong, China
      • +1 more
      Jul 21, 2009